Edesa Biotech, Inc.
EDSA
Revenue
0.00
0.000.00%
3 Months ChangeAssets
5.23M
▼-1.25M▼-19.26%
3 Months ChangeLiabilities
2.36M
▲209.90k▲9.76%
3 Months ChangeFree Cash Flow
-1.79M
▲1.42M▲44.22%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001171843-24-005928
2024-10-04
Form 8-K
ID: 0001171843-24-005515
2024-08-09
Form 10-Q
ID: 0001171843-24-004651
2024-08-09
Form 8-K
ID: 0001171843-24-004649
2024-06-24
Form 8-K
ID: 0001654954-24-008062
2024-05-30
Form 8-K
ID: 0001654954-24-007083
2024-05-10
Form 10-Q
ID: 0001654954-24-005971
2024-05-10
Form 8-K
ID: 0001654954-24-005965
2024-02-09
Form 10-Q
ID: 0001654954-24-001540
2024-02-09
Form 8-K
ID: 0001654954-24-001539